INC Research CEO reflects on Kendle acquisition
6 Minuten
Podcast
Podcaster
Beschreibung
vor 14 Jahren
INC Research CEO James Ogle tells Outsourcing-pharma.com that the
acquisition of fellow CRO Kendle was about building a presence in
emerging trial hotspots and pharmaceutical markets.
acquisition of fellow CRO Kendle was about building a presence in
emerging trial hotspots and pharmaceutical markets.
Weitere Episoden
3 Minuten
vor 11 Jahren
3 Minuten
vor 12 Jahren
5 Minuten
vor 12 Jahren
4 Minuten
vor 12 Jahren
7 Minuten
vor 12 Jahren
In Podcasts werben
Kommentare (0)